109.59MMarket Cap-14.74P/E (TTM)
5.590High4.410Low61.17KVolume5.400Open5.105Pre Close309.90KTurnover3.82%Turnover RatioLossP/E (Static)21.24MShares6.48052wk High-156.36P/B8.26MFloat Cap1.58052wk Low--Dividend TTM1.60MShs Float6.480Historical High--Div YieldTTM23.12%Amplitude1.580Historical Low5.066Avg Price1Lot Size
OS Therapies Stock Forum
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
OS Therapies Announces Positive Efficacy and Safety Data for Ovarian Cancer Therapeutic Candidate Developed Based on Tunable Antibody Drug Conjugate (tADC) Platform Using Proprietary Silicone Linker Platform in Preclinical Models
Folate receptor alpha targeting drug conjugate & hexa silanol exatecan (FRA-H) payloads tested in animal models of ovarian cancer
Strong efficacy for FRA-H in KB and IGROV-1 mouse models of ovarian cancer
Strong safety profile for FRA-H wit...
No comment yet